Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Global Medical Gloves Strategic Market Report 2023-2030 with Top Glove Dominating the Multi-Billion Industry


DUBLIN, Dec. 6, 2023 /PRNewswire/ -- The "Medical Gloves - Global Strategic Business Report" report has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo

Global Medical Gloves Market to Reach $46.9 Billion by 2030

The global market for Medical Gloves estimated at US$21.8 Billion in the year 2022, is projected to reach a revised size of US$46.9 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2022-2030. Examination Gloves, one of the segments analyzed in the report, is projected to record 10.2% CAGR and reach US$39.8 Billion by the end of the analysis period. Growth in the Surgical Gloves segment is estimated at 9.1% CAGR for the next 8-year period.

The COVID-19 pandemic had a profound impact on the production and sales of medical gloves. The increased need for personal protective equipment, including gloves, led to a surge in demand. However, this increased usage also raised concerns about skin damage due to excessive glove usage and environmental issues related to the disposal of medical waste.

The pandemic also resulted in a spike in the prices of medical gloves, with average selling prices (ASP) experiencing significant growth from the second quarter of 2020 to the first quarter of 2021. In the competitive landscape of medical gloves, key competitors vie for market share, and their competitive market presence varies from strong to niche or trivial.

The global market outlook for medical gloves indicates a wider acceptance of disposable medical gloves, with surgical gloves also experiencing healthy gains. Powder-free gloves have gained popularity due to safety concerns. Hospitals and clinics remain primary end-users of disposable medical gloves.

Medical gloves come in various types, including latex and non-latex gloves, with different benefits and drawbacks associated with each. The market includes examination gloves, surgical gloves, and both powdered and powder-free gloves. In the competitive landscape of medical gloves, various world brands play a significant role in the industry's development and innovation. Recent market activity indicates the dynamic nature of this market segment.

The U.S. Market is Estimated at $6.9 Billion, While China is Forecast to Grow at 11.7% CAGR

Geographically, developed regions continue to be major revenue contributors, while developing regions are evolving into the fastest-growing markets. Malaysia leads global glove production, with top manufacturers like Top Glove, Hartalega, Kossan, and Supermax contributing significantly to the industry.

The Medical Gloves market in the U.S. is estimated at US$6.9 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$10.1 Billion by the year 2030 trailing a CAGR of 11.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.6% and 9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.

What`s New?

MARKET TRENDS & DRIVERS

FOCUS ON SELECT PLAYERS (Total 229 Featured)

For more information about this report visit https://www.researchandmarkets.com/r/xzw4yh

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo - https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets


These press releases may also interest you

at 18:59
FINN Partners, a global independent marketing and communications agency, and Humble Ventures, a venture capital and private equity firm focused on diverse founders, entrepreneurs, start-ups and organizations, are joining forces for the second year in...

at 18:15
The "Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), and End User (Hospital, Imaging Center, Pharmaceutical) -...

at 18:00
Pacific Cataract and Laser Institute, Inc., P.C. ("Pacific Cataract and Laser") is providing notice of a recent data privacy event that may have affected the personal and protected health information related to certain individuals. At this time,...

at 18:00
The "Pharmaceutical Quality Management Systems Market by Solution Type (Deviation, CAPA, Audit, Risk & Compliance, Inspection, Document, Change, Training Management), Deployment Mode (Cloud, On-premise), and End User (Pharmaceutical, CDMO/CRO) -...

at 17:25
Spyre Therapeutics, Inc. (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel...

at 17:21
Mezzion Pharmaceuticals is a rare disease company conducting the confirmatory pivotal phase 3 clinical trial in Fontan subjects: The Fontan Udenafil Exercise Longitudinal Assessment Trial- 2, or FUEL-2 trial. The company is pleased to announce Dr....



News published on and distributed by: